Drug Delivery Trends in Clinical Trials and Translational Medicine: Evaluation of Pharmacokinetic Properties in Special PopulationsCHIEN, Jenny Y; HO, Rodney J. Y.Journal of pharmaceutical sciences. 2011, Vol 100, Num 1, pp 53-58, issn 0022-3549, 6 p.Article

Some considerations on the design of population pharmacokinetic studiesDUFFULL, Stephen; WATERHOUSE, Tim; ECCLESTON, John et al.Journal of pharmacokinetics and pharmacodynamics (Print). 2005, Vol 32, Num 3-4, pp 441-457, issn 1567-567X, 17 p.Article

Methods to Account for Inaccuracies in the Dosing History When Performing Population Pharmacokinetic AnalysisPAVAN KUMAR, Venkata V; DUFFULL, Stephen B.Pharmaceutical research. 2008, Vol 25, Num 12, pp 2740-2749, issn 0724-8741, 10 p.Article

Dose-dependency of pharmacokinetic/pharmacodynamic parameters after intravenous bolus doses of cisatracuriumCHEN, C; YAMAGUCHI, N; VARIN, F et al.British journal of anaesthesia. 2008, Vol 101, Num 6, pp 788-797, issn 0007-0912, 10 p.Article

Comparative bioavailability of two immediate-release tablets of lisinopril/hydrochlorothiazide in healthy volunteersGASCON, A. R; CUADRADO, A; SOLINIS, M. A et al.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 7, pp 309-315, issn 0946-1965, 7 p.Article

Comparative bioequivalence study of two isotretinoin soft gel capsule formulations in healthy male volunteersGEORGARAKIS, M; ZOUGROU, F; TZAVARA, S et al.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 7, pp 316-322, issn 0946-1965, 7 p.Article

Pharmacogenomics and drug responseMÜLLER, M.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 6, pp 231-240, issn 0946-1965, 10 p.Article

Pharmacokinetic-pharmacodynamic interrelationships of intravenous and oral levosimendan in patients with severe congestive heart failurePODER, P; EHA, J; SUNDBERG, S et al.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 8, pp 365-373, issn 0946-1965, 9 p.Article

Pharmacokinetics and pharmacodynamics of cisplatin after intra-operative Hyperthermic intraperitoneal chemoperfusion (HIPEC)ZEAMARI, S; FLOOT, B; VAN DER VANGE, N et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1643-1648, issn 0250-7005, 6 p.Article

Bioequivalence study of two brands of enalapril tablets after single oral administration to healthy volunteersNIOPAS, I; DAFTSIOS, A. C; NIKOLAIDIS, N et al.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 5, pp 226-230, issn 0946-1965, 5 p.Article

Pharmacokinetic and pharmacodynamic analysis of platinum after combined treatment of cisplatin and procainamide hydrochloride in mice bearing P388 leukemiaVANNOZZI, Maria O; OTTONE, Massimo; MARIGGIO, Maria A et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1509-1516, issn 0250-7005, 8 p.Article

Discrepancies in pharmacokinetic analysis results obtained by using two standard population pharmacokinetics software programsFINKELSTEIN, Yaron; NAVA-DCAMPO, Alejandro A; SCHECHTER, Tal et al.Fundamental & clinical pharmacology. 2009, Vol 23, Num 1, pp 53-57, issn 0767-3981, 5 p.Article

Dealing with time-dependent pharmacokinetics during the early clinical development of a new leukotriene B₄ synthesis inhibitorTROCONIZ, Inaki F; ZSOLT, Ilonka; GARRIDO, Maria J et al.Pharmaceutical research. 2006, Vol 23, Num 7, pp 1533-1542, issn 0724-8741, 10 p.Article

Population approaches in paediatricsCHATELUT, Etienne.Fundamental & clinical pharmacology. 2008, Vol 22, Num 6, pp 575-578, issn 0767-3981, 4 p.Conference Paper

Population pharmacokinetic analysis of carboxyhaemoglobin concentrations in adult cigarette smokersCRONENBERGER, Carol; MOULD, Diane R; ROETHIG, Hans-Juergen et al.British journal of clinical pharmacology. 2008, Vol 65, Num 1, pp 30-39, issn 0306-5251, 10 p.Article

Comparative pharmacokinetics and pharmacodynamics of propranolol and atenolol in normolipaemic and hyperlipidaemic obese subjectsWOJCICKI, Jerzy; JAROSZYNSKA, Maria; DROZDZIK, Marek et al.Biopharmaceutics & drug disposition. 2003, Vol 24, Num 5, pp 211-218, issn 0142-2782, 8 p.Article

Bioavailability, disposition, and dose-response effects of soy isoflavones when consumed by healthy women at physiologically typical dietary intakesSETCHELL, Kenneth D. R; BROWN, Nadine Maynard; DESAI, Pankaj B et al.The Journal of nutrition. 2003, Vol 133, Num 4, pp 1027-1035, issn 0022-3166, 9 p.Article

Effect of severe renal impairment on the pharmacokinetics and tolerability of the parenteral endothelin antagonist tezosentanVAN GIERSBERGEN, P. L. M; DINGEMANSE, J.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 6, pp 261-266, issn 0946-1965, 6 p.Article

Pharmacokinetics and biodistribution of ⁸⁶Y-trastuzumab for ⁹⁰Y dosimetry in an ovarian carcinoma model: Correlative micropet and MRIPALM, Stig; ENMON, Richard M; MATEI, Cornelia et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 7, pp 1148-1155, issn 0161-5505, 8 p.Article

The effects of the cyclosporin A, a P-glycoprotein inhibitor, on the pharmacokinetics of baicalein in the rat: a microdialysis studyTSAI, T. H; LIU, S. C; TSAI, P. L et al.British journal of pharmacology. 2002, Vol 137, Num 8, pp 1314-1320, issn 0007-1188, 7 p.Article

The influence of weightlessness on pharmacokineticsGANDIA, Peggy; SAIVIN, Sylvie; HOUIN, Georges et al.Fundamental & clinical pharmacology. 2005, Vol 19, Num 6, pp 625-636, issn 0767-3981, 12 p.Article

Modelling ocular pharmacokinetics of fluorescein administered as lyophilisate or conventional eye dropsABDULJALIL, Khaled; DIESTELHORST, Michael; DOROSHYENKO, Oxana et al.European journal of clinical pharmacology. 2008, Vol 64, Num 5, pp 521-529, issn 0031-6970, 9 p.Article

Time dependent pharmacokinetics of albendazole in humanMIRFAZAELIAN, A; ROUINI, M. R; DADASHZADEH, S et al.Biopharmaceutics & drug disposition. 2003, Vol 24, Num 5, pp 199-204, issn 0142-2782, 6 p.Article

Pharmacokinetic models for propofol―defining and illuminating the devil in the detailABSALOM, A. R; MANI, V; DE SMET, T et al.British journal of anaesthesia. 2009, Vol 103, Num 1, pp 26-37, issn 0007-0912, 12 p.Article

Mechanistic modelling of tesaglitazar pharmacokinetic data in subjects with various degrees of renal function -evidence of interconversionHAMREN, Bengt; ERICSSON, Hans; SAMUELSSON, Ola et al.British journal of clinical pharmacology. 2008, Vol 65, Num 6, pp 855-863, issn 0306-5251, 9 p.Article